WVE

Wave Life Sciences Ltd.

NASDAQHealthcareBiotechnologySG

Rating:C-

CEO

Paul Bolno

IPO Date

2015-11-11

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

News SentimentNeutral

Articles

Avg Positive

23.7%

Avg Negative

21.2%

Avg Neutral

55.2%

News Feed

Wave Life Sciences' RNA Editing Platform Shows Restoration of Functional AAT Protein in Preclinical Study

Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in Alpha-1 Antitrypsin Deficiency

Wave Life Sciences to Present at Jefferies Virtual Healthcare Conference